Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 44

1.

A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia.

Pandina GJ, Lindenmayer JP, Lull J, Lim P, Gopal S, Herben V, Kusumakar V, Yuen E, Palumbo J.

J Clin Psychopharmacol. 2010 Jun;30(3):235-44. doi: 10.1097/JCP.0b013e3181dd3103. Erratum in: J Clin Psychopharmacol. 2010 Aug;30(4):364.

PMID:
20473057
2.

Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder.

Quiroz JA, Yatham LN, Palumbo JM, Karcher K, Kushner S, Kusumakar V.

Biol Psychiatry. 2010 Jul 15;68(2):156-62. doi: 10.1016/j.biopsych.2010.01.015. Epub 2010 Mar 15.

PMID:
20227682
3.

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.

Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.

Bipolar Disord. 2009 Nov;11(7):687-700. doi: 10.1111/j.1399-5618.2009.00750.x.

PMID:
19839994
4.

Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: double-blind study.

Haas M, Eerdekens M, Kushner S, Singer J, Augustyns I, Quiroz J, Pandina G, Kusumakar V.

Br J Psychiatry. 2009 Feb;194(2):158-64. doi: 10.1192/bjp.bp.107.046177.

5.

Maintenance study for adolescent depression.

Cheung A, Kusumakar V, Kutcher S, Dubo E, Garland J, Weiss M, Kiss A, Levitt A.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):389-94. doi: 10.1089/cap.2008.0001.

PMID:
18759650
6.

Pituitary gland volume in adolescent and young adult bipolar and unipolar depression.

MacMaster FP, Leslie R, Rosenberg DR, Kusumakar V.

Bipolar Disord. 2008 Feb;10(1):101-4. doi: 10.1111/j.1399-5618.2008.00476.x.

PMID:
18199247
7.

Online health promotion, early identification of difficulties, and help seeking in young people.

Santor DA, Poulin C, LeBlanc JC, Kusumakar V.

J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):50-9.

PMID:
17195729
8.

Examining school health center utilization as a function of mood disturbance and mental health difficulties.

Santor DA, Poulin C, LeBlanc JC, Kusumakar V.

J Adolesc Health. 2006 Nov;39(5):729-35. Epub 2006 Jul 10.

PMID:
17046510
9.

Choline in pediatric depression.

MacMaster FP, Kusumakar V.

Mcgill J Med. 2006 Jan;9(1):24-7.

10.

Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials.

LeBlanc JC, Binder CE, Armenteros JL, Aman MG, Wang JS, Hew H, Kusumakar V.

Int Clin Psychopharmacol. 2005 Sep;20(5):275-83.

PMID:
16096518
11.

Open-label adjunctive topiramate in the treatment of unstable bipolar disorder.

McIntyre RS, Riccardelli R, Binder C, Kusumakar V.

Can J Psychiatry. 2005 Jun;50(7):415-22.

PMID:
16086539
12.

Growth and sexual maturation during long-term treatment with risperidone.

Dunbar F, Kusumakar V, Daneman D, Schulz M.

Am J Psychiatry. 2004 May;161(5):918-20.

PMID:
15121661
13.

Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.

Yatham LN, Binder C, Kusumakar V, Riccardelli R.

Int Clin Psychopharmacol. 2004 Mar;19(2):103-9.

PMID:
15076019
14.

The characteristics of asymptomatic female adolescents at high risk for depression: the baseline assessment from a prospective 8-year study.

Kutcher S, Kusumakar V, LeBlanc J, Santor D, Lagace D, Morehouse R.

J Affect Disord. 2004 Apr;79(1-3):177-85.

PMID:
15023492
15.

MRI study of the pituitary gland in adolescent depression.

MacMaster FP, Kusumakar V.

J Psychiatr Res. 2004 May-Jun;38(3):231-6.

PMID:
15003427
16.

Hippocampal volume in early onset depression.

MacMaster FP, Kusumakar V.

BMC Med. 2004 Jan 29;2:2.

17.

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.

Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S.

Eur Neuropsychopharmacol. 2004 Jan;14(1):11-28. Review.

PMID:
14659983
18.

Prolactin levels during long-term risperidone treatment in children and adolescents.

Findling RL, Kusumakar V, Daneman D, Moshang T, De Smedt G, Binder C.

J Clin Psychiatry. 2003 Nov;64(11):1362-9.

PMID:
14658952
19.

Risperidone in acute and continuation treatment of mania.

Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V; RIS-CAN 25 Study Group.

Int Clin Psychopharmacol. 2003 Jul;18(4):227-35.

PMID:
12817157
20.

Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference.

Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller EB, Wozniak J, Youngstrom EA.

J Child Adolesc Psychopharmacol. 2003 Spring;13(1):13-27. Review.

PMID:
12804123
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk